Stocks
Teva Pharmaceutical Industries (TEVA) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -7.15% | -39.8% | 4.06% | -29.8% | -7.45% | 11.4% | ||
| Changes by years, y/y, % | +7pp | -33pp | +44pp | -34pp | +22pp | -12.6% | |||
Teva Pharmaceutical Industries. ROE, %
Teva Pharmaceutical Industries. ROE, changes, pp
Teva Pharmaceutical Industries (TEVA) ROE US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| ROE, % | ? | -31.7% | -31.9% | -6.49% | -7.45% | -6.77% | 11.4% | |
| Changes by years, y/y, % | -20pp | -17pp | +24pp | +23pp | +14pp | |||
| Changes by quarters, q/q, % | -11pp | 0pp | +25pp | -1pp | +1pp | |||
